
Results
12
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
12 companies
AddLife
Market Cap: SEK 19.3b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 158.40
7D
2.1%
1Y
-17.9%
Bonesupport Holding
Market Cap: SEK 14.4b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 218.20
7D
-3.2%
1Y
-17.6%
Swedencare
Market Cap: SEK 4.2b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 26.15
7D
-1.7%
1Y
-35.3%
Devyser Diagnostics
Market Cap: SEK 1.5b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 89.80
7D
-5.1%
1Y
-21.5%
Xspray Pharma
Market Cap: SEK 748.2m
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 15.78
7D
1.8%
1Y
-60.3%
Cinclus Pharma Holding
Market Cap: SEK 550.1m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 11.82
7D
-4.1%
1Y
-34.0%
Mendus
Market Cap: SEK 343.6m
A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.
IMMU
SEK 5.60
7D
9.8%
1Y
-23.4%
Promimic
Market Cap: SEK 200.3m
Engages in the manufacturing, marketing, and sale of biomaterials for improved osseointegration in the orthopedic and dental implants markets in Sweden.
PRO
SEK 10.60
7D
-3.6%
1Y
-41.6%
Diamyd Medical
Market Cap: SEK 172.3m
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 1.11
7D
-0.2%
1Y
-88.5%
IDL Diagnostics
Market Cap: SEK 101.8m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.44
7D
-11.4%
1Y
-17.8%
Alzinova
Market Cap: SEK 74.1m
A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.
ALZ
SEK 0.48
7D
4.0%
1Y
-70.7%
PharmaLundensis
Market Cap: SEK 15.3m
PharmaLundensis AB operates as a pharmaceutical company.
PHAL
SEK 0.36
7D
0%
1Y
-44.6%